Abstract:Background: Although there are many benign tumors in the ovarian adnexal area, the four most common types are still luteal cyst, ovarian mature cystic teratoma (OMCT), ovarian endometriosis, and benign epithelial tumors of the ovary. Purpose: This study aimed to examine the correlation between six tumor markers (CEA, AFP, CA125, CA19-9, SCC, HE4) in the differential diagnosis of female adnexal benign masses and assess their diagnostic value. Patients and methods: In this study, 135 patients with adnexal benign masses were treated in Zhengzhou first people's Hospital from January 2018 to January 2023. 135 patients were divided into four groups: luteal cyst (13.3%), OMCT (42.2%), ovarian endometriosis (23.7%) and benign epithelial tumors of the ovary (including mucinous cystadenoma and serous cystadenoma) in group D. The receiver-operating characteristic (ROC) curve was used to assess the diagnostic value of each marker and combined detection. Results: The diameter of luteal cysts was significantly smaller than that of benign ovarian tumors (p < 0.001). ROC analysis showed that the combination of AFP, CA125, CA19-9, and SCC had a higher diagnostic rate for luteal cysts (AUC=0.871; sensitivity: 71.8%; specificity: 88.9). The SCC level in OMCT was significantly higher than in other benign ovarian tumors (p=0.007). ROC analysis indicated that the combination of AFP, HE4, and SCC had a higher diagnostic rate for OMCT (AUC=0.753; sensitivity: 65.4%; specificity: 75.4%). The CA125 level in ovarian endometriosis was significantly higher than in other accessory benign tumors (p < 0.001). ROC analysis demonstrated that the combination of AFP, CA125, and CA19-9 had a higher diagnostic rate for ovarian endometriosis (AUC=0.935; sensitivity: 76.7%; specificity: 96.9%). The tumor diameter of benign epithelial tumors of the ovary was significantly larger than that of other benign ovarian tumors (p < 0.001). ROC analysis revealed that the combination of CA125 and CA19-9 had a higher diagnostic rate for benign epithelial tumors of the ovary (AUC=0.792; sensitivity: 64.5%; specificity: 85.7%). Conclusion: The findings of this study demonstrate that the combined use of tumor markers (CEA, AFP, CA125, CA19-9, SCC, and HE4) has value in diagnosing benign ovarian tumors, including luteal cysts, OMCT, ovarian endometriosis, and benign epithelial tumors of the ovary. However, it is important to acknowledge the limitations of this study, which include its single-center nature and the small sample size. Despite these limitations, the results highlight the potential utility of these markers in clinical practice.

Comparison of the clinical characteristics of ovarian lymphoma and ovarian cancer with bulk lymph node involvement

Comparison of the clinical characteristics and prognosis between clear cell carcinomas and high-grade serous ovarian carcinomas

Histological Classification in 10 288 Cases of Ovarian Malignant Tumors in China

Comparison of diagnostic values between CA125 combined with CA199 and ultrasound combined with CT in ovarian cancer

The present state of primary ovarian lymphoma: a case report and twenty years of analysis

A Real-World Observational Study To Explore Clinical Characteristics Of Chinese Patients With T1 Non-Small Cell Lung Cancer Complicated With Lymph Metastases.

Comparison of Laparoscopic and Laparotomic Staging of Early-stage Ovarian Cancer

Ultrasonographic manifestations and misdiagnosis analysis of ovarian leiomyoma

Comparison of the diagnostic efficacy of systemic inflammatory indicators in the early diagnosis of ovarian cancer

Unusual Presentation of Primary Ovarian Diffuse Large B-cell Lymphoma: a Case Report

Differentiating primary from metastatic ovarian tumors of gastrointestinal origin by CT

Comparison of pure and mixed-type clear cell carcinoma of the ovary: a clinicopathological analysis of 341 Chinese patients

Preoperative LMR and Serum CA125 Level as Risk Factors for Advanced Stage of Ovarian Cancer

Tumor Markers in Differential Diagnosis of Benign Ovarian Masses

Laparoscopic versus laparotomic surgical treatment in apparent stage I ovarian cancer: a multi-center retrospective cohort study

Comparison and Analysis of the Clinicopathological Features of SCEO and ECOM

Clinical Features and Treatment Outcomes of 14 Cases of Primary Ovarian Non-Hodgkin’s Lymphoma: a Single-Center Experience

Comparison between Primary Peritoneal Carcinoma and Ovarian Serous a Denocarcinoma: A Study of Clinical Biological Behavior and Expression of Tumor Marker

OC12.03: Comparison of clinical and ultrasound characteristics in low‐ and high‐grade serous cancer

A Retrospective Comparative Study On Epithelial Ovarian Carcinomas Arising From And Concomitant With Endometriosis

The impact of lymphadenectomy on the survival outcomes of ovarian clear cell carcinoma: A retrospective study of the SEER database and Chinese registry